Last reviewed · How we verify
NCT06358963
CoQ10 and Omega-3 as Adjuncts to Periodontal Therapy, TAC of Saliva.
NA trial testing Receive 30 mg of Coq10 in Periodontal Diseases in 80 participants. Enrolling by invitation.
20 April 2024
Quick facts
| Lead sponsor | Amirhossein Farahmand |
|---|---|
| Phase | NA |
| Status | ENROLLING BY INVITATION |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | treatment |
| Enrollment | 80 |
| Start date | 20 February 2024 |
| Primary completion | 20 April 2024 |
| Estimated completion | 10 May 2024 |
| Sites | 1 location across Iran |
Drugs / interventions tested
- Receive 30 mg of Coq10 — full drug profile →
- Non-Medicare Drugs — full drug profile →
Conditions studied
- Periodontal Diseases — all drugs for Periodontal Diseases →
Sponsor
Amirhossein Farahmand — full company profile →
Who can join
Adults 28 to 35, any sex, with Periodontal Diseases. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Comparative evaluation of CoQ10 and Omega-3 as adjuncts to periodontal therapy and total antioxidant capacity of saliva (randomized Double-Blind Clinicalials)
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Comparative assessment of Omega-3 and CoQ10 as adjuncts to periodontal therapy and total antioxidant capacity of saliva in patients with chronic periodontitis: A double-blind, randomized clinical trial.
Farahmand A, Talebi M, Ramezani F, Karami R, et al · · 2024 · cited 1× · PMID 40952889 · DOI 10.1016/j.sdentj.2024.09.014
Verify or expand the search:
- PubMed search for NCT06358963
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Receive 30 mg of Coq10
Trials testing the same drug.
- NCT06373848 — Non-surgical Treatment of Chronic Periodontitis With an Adjunctive Vitamin E and Coenzyme Q10 Supplementation · NA · enrolling by invitation
Other recruiting trials for Periodontal Diseases
Currently open trials in the same condition.
- NCT07358104 — Efficacy of Camel Whey Protein and Camel Whey Protein Nanoparticles for Treating Intra-bony Periodontal Defects · NA · active not recruiting
- NCT07312045 — HALP Score, Blood-Based Inflammatory Indices, and Salivary MMP-8 in Periodontal Disease and Healing After Non-Surgical T · recruiting
- NCT07384221 — Periodontal Status and Disease Severity in Pemphigus Vulgaris Patients · recruiting
- NCT07530978 — ORAL HYGIENE, PERIODONTAL STATUS AND QUALITY OF LIFE · recruiting
- NCT06848790 — Interdental Hygiene Methods in Young Adults · NA · recruiting
Other Amirhossein Farahmand trials
Trials by the same sponsor.
- NCT03836781 — Teh Effect of Subgingival Irrigation Wif Ketorolac and Chlorhexidine in Patients Wif Chronic Periodontist · Phase 2, PHASE3 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06358963 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Amirhossein Farahmand
- Last refreshed: 17 April 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06358963.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing